Ambrx Biopharma Cayman Inc (AMAM)

Ticker: AMAM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ambrx Biopharma Cayman Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
HOPU Reunion Co Ltd Affiliated with former director Non-Executive Director
Transaction date
Proposed sale
Price
242.34
Quantity 55,814
Value US$182,526
HOPU Reunion Co Ltd Affiliated with former director Non-Executive Director
Transaction date
Proposed sale
Price
267.23
Quantity 89,428
Value US$4,281,326
HOPU Reunion Co Ltd Affiliated with former director Non-Executive Director
Transaction date
Proposed sale
Price
322.58
Quantity 94,164
Value US$4,530,851
HOPU Reunion Co Ltd Affiliated with former director Non-Executive Director
Transaction date
Proposed sale
Price
12.02
Quantity 1,000,000
Value US$12,020,000
HOPU Reunion Co Ltd Affiliated with former director Non-Executive Director
Transaction date
Proposed sale
Price
11.72
Quantity 600,000
Value US$7,032,000
Transaction date
Proposed sale
Price
9.82
Quantity 50,012
Value US$491,168
Nelson Sonja Chief Financial Officer Officer
Transaction date
Planned sale
Price
9.82
Quantity 12,778 -8.9%
Value US$125,480
3.2
O'Connor Daniel J. President and CEO Executive Director
Transaction date
Planned sale
Price
9.82
Quantity 50,012 -12.7%
Value US$491,118
Transaction date
Proposed sale
Price
9.82
Quantity 12,778
Value US$125,493
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-12-26 2023-12-26 PrS Proposed sale

Affiliated with former director

Non-Executive Director
55,814
242.34
US$182,526
55,814 242.34 US$182,526
2023-12-19 2023-12-19 PrS Proposed sale

Affiliated with former director

Non-Executive Director
89,428
267.23
US$4,281,326
89,428 267.23 US$4,281,326
2023-12-08 2023-12-08 PrS Proposed sale

Affiliated with former director

Non-Executive Director
94,164
322.58
US$4,530,851
94,164 322.58 US$4,530,851
2023-12-05 2023-12-05 PrS Proposed sale

Affiliated with former director

Non-Executive Director
1,000,000
12.02
US$12,020,000
1,000,000 12.02 US$12,020,000
2023-12-01 2023-12-01 PrS Proposed sale

Affiliated with former director

Non-Executive Director
600,000
11.72
US$7,032,000
600,000 11.72 US$7,032,000
2023-11-01 2023-10-27 PrS Proposed sale

CEO

50,012
9.82
US$491,168
50,012 9.82 US$491,168
2023-10-31 2023-10-27 PlS Planned sale

Chief Financial Officer

Officer
12,778 -8.9%
9.82
US$125,480
12,778 -8.9% 9.82 US$125,480
2023-10-31 2023-10-27 PlS Planned sale

President and CEO

Executive Director
50,012 -12.7%
9.82
US$491,118
50,012 -12.7% 9.82 US$491,118
2023-10-27 2023-10-27 PrS Proposed sale

CFO

12,778
9.82
US$125,493
12,778 9.82 US$125,493
2023-10-25 2023-10-23 B Purchase Large shareholder
1,307,311 +13.2%
6.99
US$9,139,542
1,307,311 +13.2% 6.99 US$9,139,542
2023-09-19 2023-09-18 B Purchase Large shareholder
751,233 +1.1%
9.24
US$6,944,924
751,233 +1.1% 9.24 US$6,944,924
2023-09-19 2023-09-15 B Purchase Large shareholder
1,401,505 +2.1%
9.05
US$12,680,677
1,401,505 +2.1% 9.05 US$12,680,677
2023-04-20 2023-04-20 B Purchase Large shareholder
886,634 +1.3%
11.60
US$10,285,220
886,634 +1.3% 11.60 US$10,285,220
2023-04-20 2023-04-19 B Purchase Large shareholder
951,909 +1.5%
11.15
US$10,612,357
951,909 +1.5% 11.15 US$10,612,357
2023-04-20 2023-04-18 B Purchase Large shareholder
3,376,646 +5.4%
11.27
US$38,053,112
3,376,646 +5.4% 11.27 US$38,053,112
2023-04-17 2023-04-17 B Purchase Large shareholder
562,121 +0.9%
10.67
US$5,999,461
562,121 +0.9% 10.67 US$5,999,461
2023-04-17 2023-04-14 B Purchase Large shareholder
841,967 +1.4%
9.96
US$8,384,307
841,967 +1.4% 9.96 US$8,384,307
2023-04-17 2023-04-13 B Purchase Large shareholder
1,193,808 +2.0%
9.16
US$10,935,520
1,193,808 +2.0% 9.16 US$10,935,520
2023-03-16 2023-03-16 B Purchase Large shareholder
500,000 +0.9%
10.15
US$5,074,250
500,000 +0.9% 10.15 US$5,074,250
2023-03-16 2023-03-15 B Purchase Large shareholder
250,000 +0.5%
10.60
US$2,648,875
250,000 +0.5% 10.60 US$2,648,875
2023-03-16 2023-03-14 B Purchase Large shareholder
250,000 +0.5%
9.95
US$2,488,275
250,000 +0.5% 9.95 US$2,488,275